Date: 2013-06-13
Type of information: Fundraising
Company: apceth (Germany)
Investors: existing investors
Amount: € 22 million
Funding type: financing round
Planned used: This will enable apceth to further develop its innovative cellular therapeutics right up to the clinical testing stage.
Others: * On June 13, 2013, apceth has announced that the company has just concluded another round of financing of € 22 m from their existing investors.
Therapeutic area:
